Lord, Abbett & Co
ANAB icon

Lord, Abbett & Co’s AnaptysBio ANAB Stock Holding History

Lord, Abbett & Co’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-44,408
Closed -$2.5M – 701
2019
Q2 		$2.5M Buy
44,408
+2,545
+6% +$183K 0.01% 690
2019
Q1 		$3.06M Buy
41,863
+1,213
+3% +$83.7K 0.01% 682
2018
Q4 		$2.59M Sell
40,650
-140,824
-78% -$10.5M 0.01% 724
2018
Q3 		$18.1M Buy
+181,474
New +$15.1M 0.05% 497

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lord, Abbett & Co's ANAB Position: Q3 2019 in Review

Lord, Abbett & Co sold out of AnaptysBio (ANAB) in Q3 2019, closing a stake of 44,408 shares — an estimated $2.5M sold.

Lord, Abbett & Co first reported a position in ANAB in Q3 2018 and held it in 4 quarters. The position peaked at $18.1M in Q3 2018. 119 funds tracked by Wall St. Rank hold ANAB as of Q3 2019.

  • Lord, Abbett & Co reported no remaining AnaptysBio position as of Q3 2019 after selling out during the quarter.
  • Lord, Abbett & Co sold 44,408 AnaptysBio shares in Q3 2019, an estimated $2.5M.
  • Lord, Abbett & Co first reported a position in AnaptysBio in Q3 2018 and held it in 4 quarters.
  • Lord, Abbett & Co's AnaptysBio position peaked at $18.1M in Q3 2018.
  • 119 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2019.

Based on Lord, Abbett & Co's 13F filing for Q3 2019, filed 14 Nov 2019.